K. Hirtenlehner

发表

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy

K. Hoffmann‐Sommergruber, H. Rheinberger, H. Breiteneder, 1996, The Journal of experimental medicine.

MMP-2 and MMP-9 Expression in Breast Cancer-Derived Human Fibroblasts is Differentially Regulated by Stromal-Epithelial Interactions

E. Kubista, M. Seifert, C. Singer, 2002, Breast Cancer Research and Treatment.

Influences of stroma-derived growth factors on the cytokine expression pattern of human breast cancer cell lines

E. Kubista, C. Singer, M. Péč, 2002, Archives of Gynecology and Obstetrics.

Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy.

R. Valenta, H. Eichler, P. Valent, 1997, The Journal of clinical investigation.

Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1

P. Hufnagl, C. Akdis, R. Valenta, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Immunog lobu l in E and T Lymphocyte Reactivity o f Isoforms o f the Major Birch Pollen Allergen Bet v 1 : Potential Use o f Hypoallergenic Isoforms for Immunotherapy

K. Hoffmann‐Sommergruber, R. Grimm, M. Breitenbach, 2003 .

BRCA1‐related breast cancer in Austrian breast and ovarian cancer families: Specific BRCA1 mutations and pathological characteristics

P. Oefner, T. Helbich, Å. Borg, 1998, International journal of cancer.

Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations.

P. Underhill, P. Shen, P. Oefner, 1999, Human molecular genetics.

From Molecular Science to the Treatment of Allergy

M. Manns, Jane Wilkinson, P. Hufnagl, 1999, International Archives of Allergy and Immunology.

Elevated Serum Concentrations of the Angiogenesis Inhibitor Endostatin in Preeclamptic Women

M. Wolschek, C. Lichtenberger, P. Husslein, 2003, The Journal of the Society for Gynecologic Investigation: JSGI.

Genetic Engineering of Recombinant Hypoallergenic Oligomers of the Major Birch Pollen Allergen, Bet v 1: Candidates for Specific Immunotherapy

P. Hufnagl, R. Valenta, B. Binder, 1999, International Archives of Allergy and Immunology.

Division of the major birch pollen allergen, Bet v 1, into two non-anaphylactic fragments.

R. Valenta, H. Eichler, P. Valent, 1997, International archives of allergy and immunology.

Founding BRCA1 mutations in Austrian HBOC families

P. Underhill, E. Kubista, H. Breiteneder, 1997 .